
Elvina Almuradova/LinkedIn
Jul 2, 2025, 09:34
Elvina Almuradova: Our New Paper on RAS Mutations in mCRC is Just Out in Medicina
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared a post on X about a paper she co-authored with colleagues published in Medicina:
“Our New paper on RAS mutations in mCRC is just out in Medicina! KRAS/NRAS, resistance, new G12C inhibitors and more.”
Title: RAS Mutations in Advanced Colorectal Cancer: Mechanisms, Clinical Implications, and Novel Therapeutic Approaches
Authors: Osman Sütcüoğlu, Hasan Çağrı Yıldırım, Elvina Almuradova, Damla Günenç, Şuayib Yalçın.
You can read the Full Article in Medicina.
More posts featuring Elvina Almuradova.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 2, 2025, 13:19
Jul 2, 2025, 11:38